{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:55:57Z","timestamp":1761512157916,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2882,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.seizure.2005.08.005","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T07:11:29Z","timestamp":1128582689000},"page":"490-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Levetiracetam in patients with refractory epilepsy: Results of the SKATE trial in Austria, Germany and Switzerland"],"prefix":"10.1016","volume":"14","author":[{"given":"Bernhard J.","family":"Steinhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Gregor","family":"Wieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2005.08.005_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1528-1157.1998.tb01361.x","article-title":"ILAE Commission report. Commission on outcome measurement in epilepsy, 1994\u20131997: final report","volume":"39","author":"Baker","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.005_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory focal seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.005_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.08.005_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission on Classification Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.005_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1528-1157.1996.tb00612.x","article-title":"A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10","volume":"37","author":"Cramer","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.005_bib6","first-page":"349","article-title":"EEC note for guidance: medical products for the treatment of epileptic disorders","volume":"67","author":"CPMP Working Party on Efficacy of Medicinal Products","year":"1990","journal-title":"Pharmacol Toxicol"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2005.08.005_bib7","first-page":"9","article-title":"Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam","volume":"5","author":"Klitgaard","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2005.08.005_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.seizure.2005.08.005_bib9","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.seizure.2005.08.005_bib10","series-title":"Antiepileptic drugs","first-page":"419","author":"Margineanu","year":"2002"},{"key":"10.1016\/j.seizure.2005.08.005_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The KEEPER\u2122 Trial: levetiracetam adjunctive treatment of partial onset seizures in an open-label community based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2005.08.005_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.seizure.2005.08.005_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2005.08.005_bib14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter, double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:33:35Z","timestamp":1761010415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131105001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1059131105001482"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2005.08.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam in patients with refractory epilepsy: Results of the SKATE trial in Austria, Germany and Switzerland","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2005.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}